Account
News
18.06.2024
HTAi Annual Meeting 2024

We summarise the key discussions from HTAi 2024, with a focus on sustainability, networks and innova...

Read more
Insider Insights
17.06.2024
Health Technology Assessment: HTACG provide update...

We discuss the updates on EU HTA from the June meeting of the Member State Coordination Group on Hea...

Read more
Articles
29.05.2024
EU HTA regulation

Learn how to navigate the upcoming EU HTA regulation and optimise market access strategies for oncol...

Read more
Articles
21.05.2024
How are local markets adapting their HTA evaluatio...

Our experts analyse how local European markets are integrating the EU HTA outputs into national proc...

Read more
Articles
15.05.2024
Navigating the new EU HTA regulation: organisation...

Our latest article summarises the key changes to be aware of for the upcoming EU HTA, as well as imp...

Read more
Articles
24.01.2024
What are the 5 Pricing & Market Access trends...

Our experts provide an overview of the five key trends that could shape the pricing and market acces...

Read more
Articles
01.11.2023
World Orphan Drug Congress Europe 2023 REPORT

We summarise the World Orphan Drug Congress Europe 2023 including keynote and panel sessions on EU H...

Read more
Publications
25.10.2023
ISPOR Europe 2023: Can Just Three PICOs be Feasibl...

This research aims to understand if just three PICOs are feasible by analysing recent HTA assessment...

Read more
Publications
25.10.2023
ISPOR Europe 2023: How Aware Are Biotech and Pharm...

Our research aims to gauge awareness of the new EU HTA process within the pharmaceutical industry in...

Read more
Insider Insights
12.09.2023
New Additions to HTA International Collaboration

In a ground breaking move, the international collaboration among six prominent health technology ass...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.